Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-09 | Edwards Lifesciences Corp | Lippis Daniel J.
(CVP, JAPAC) |
S | Common Stock | D | 857 | $92.34 - $92.34 | $79,135 |
| 2024-04-09 | Edwards Lifesciences Corp | Lippis Daniel J.
(CVP, JAPAC) |
M | Common Stock | A | 857 | $36.75 - $36.75 | $31,494 |
| 2024-04-08 | Edwards Lifesciences Corp | Lemercier Jean-Luc M
(CVP, EMEACLA) |
S | Common Stock | D | 14400 | $92.32 - $92.65 | $1,329,471 |
| 2024-04-08 | Edwards Lifesciences Corp | Lemercier Jean-Luc M
(CVP, EMEACLA) |
M | Common Stock | A | 14400 | $36.75 - $36.75 | $529,200 |
| 2024-04-08 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
S | Common Stock | D | 12500 | $92.33 - $92.66 | $1,154,141 |
| 2024-04-08 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
M | Common Stock | A | 12500 | $36.75 - $36.75 | $459,375 |
| 2024-04-04 | Edwards Lifesciences Corp | MUSSALLEM MICHAEL A
(Director) |
S | Common Stock | D | 29350 | $91.54 - $94.19 | $2,712,416 |
| 2024-04-04 | Edwards Lifesciences Corp | MUSSALLEM MICHAEL A
(Director) |
M | Common Stock | A | 29350 | $36.75 - $36.75 | $1,078,612 |
| 2024-04-01 | Edwards Lifesciences Corp | Ullem Scott B.
(CVP, Chief Financial Officer) |
S | Common Stock | D | 7255 | $94.81 - $95.51 | $688,422 |
| 2024-04-01 | Edwards Lifesciences Corp | Ullem Scott B.
(CVP, Chief Financial Officer) |
M | Common Stock | A | 7255 | $36.75 - $36.75 | $266,621 |
| 2024-03-13 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
S | Common Stock | D | 14500 | $91.01 - $91.01 | $1,319,695 |
| 2024-03-13 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
M | Common Stock | A | 14500 | $36.75 - $36.75 | $532,875 |
| 2024-03-11 | Edwards Lifesciences Corp | Lemercier Jean-Luc M
(CVP, EMEACLA and JAPAC) |
S | Common Stock | D | 14400 | $91.68 - $91.68 | $1,320,148 |
| 2024-03-11 | Edwards Lifesciences Corp | Lemercier Jean-Luc M
(CVP, EMEACLA and JAPAC) |
M | Common Stock | A | 14400 | $36.75 - $36.75 | $529,200 |
| 2024-03-07 | Edwards Lifesciences Corp | Lippis Daniel J.
(CVP, JAPAC) |
S | Common Stock | D | 1715 | $90.98 - $90.98 | $156,030 |
| 2024-03-07 | Edwards Lifesciences Corp | Lippis Daniel J.
(CVP, JAPAC) |
M | Common Stock | A | 1715 | $36.75 - $36.75 | $63,026 |
| 2024-03-04 | Edwards Lifesciences Corp | MUSSALLEM MICHAEL A
(Director) |
S | Common Stock | D | 29350 | $86.21 - $87.05 | $2,543,737 |
| 2024-03-04 | Edwards Lifesciences Corp | MUSSALLEM MICHAEL A
(Director) |
M | Common Stock | A | 29350 | $36.75 - $36.75 | $1,078,612 |
| 2024-02-23 | Edwards Lifesciences Corp | GALLAHUE KIERAN
(Director) |
S | Common Stock | D | 3058 | $87.61 - $87.61 | $267,911 |
| 2024-02-23 | Edwards Lifesciences Corp | GALLAHUE KIERAN
(Director) |
M | Common Stock | A | 7056 | $36.86 - $36.86 | $260,107 |
| 2024-02-23 | Edwards Lifesciences Corp | GALLAHUE KIERAN
(Director) |
G | Common Stock | D | 14112 | $0.00 - $0.00 | $0 |
| 2024-02-22 | Edwards Lifesciences Corp | SELLERS ROBERT W.A.
(SVP, Corporate Controller) |
A | Common Stock | A | 1998 | $0.00 - $0.00 | $0 |
| 2024-02-22 | Edwards Lifesciences Corp | Szyman Catherine M.
(CVP, Critical Care) |
A | Common Stock | A | 8560 | $0.00 - $0.00 | $0 |
| 2024-02-21 | Edwards Lifesciences Corp | Chopra Daveen
(CVP, TMTT) |
S | Common Stock | D | 8200 | $86.67 - $86.75 | $711,271 |
| 2024-02-21 | Edwards Lifesciences Corp | Chopra Daveen
(CVP, TMTT) |
M | Common Stock | A | 7000 | $59.26 - $59.26 | $414,796 |
| 2024-02-16 | Edwards Lifesciences Corp | Ullem Scott B.
(CVP, Chief Financial Officer) |
F | Common Stock | D | 174 | $86.04 - $86.04 | $14,970 |
| 2024-02-16 | Edwards Lifesciences Corp | Wood Larry L
(Global President TAVR & Surg) |
F | Common Stock | D | 317 | $86.04 - $86.04 | $27,274 |
| 2024-02-13 | Edwards Lifesciences Corp | Szyman Catherine M.
(CVP, Critical Care) |
S | Common Stock | D | 47000 | $85.62 - $86.46 | $4,040,852 |
| 2024-02-13 | Edwards Lifesciences Corp | Szyman Catherine M.
(CVP, Critical Care) |
M | Common Stock | A | 47000 | $36.75 - $36.75 | $1,727,250 |
| 2024-02-12 | Edwards Lifesciences Corp | SELLERS ROBERT W.A.
(SVP, Corporate Controller) |
S | Common Stock | D | 12210 | $87.00 - $87.00 | $1,062,270 |
| 2024-02-12 | Edwards Lifesciences Corp | SELLERS ROBERT W.A.
(SVP, Corporate Controller) |
M | Common Stock | A | 12210 | $36.75 - $36.75 | $448,717 |
| 2024-02-08 | Edwards Lifesciences Corp | STONE HEISZ LESLIE
(Director) |
S | Common Stock | D | 7056 | $86.45 - $86.45 | $609,991 |
| 2024-02-08 | Edwards Lifesciences Corp | STONE HEISZ LESLIE
(Director) |
M | Common Stock | A | 7056 | $36.86 - $36.86 | $260,107 |
| 2024-02-05 | Edwards Lifesciences Corp | MUSSALLEM MICHAEL A
(Director) |
S | Common Stock | D | 29350 | $86.44 - $89.61 | $2,567,751 |
| 2024-02-05 | Edwards Lifesciences Corp | MUSSALLEM MICHAEL A
(Director) |
M | Common Stock | A | 29350 | $36.75 - $36.75 | $1,078,612 |
| 2024-02-01 | Edwards Lifesciences Corp | Ullem Scott B.
(CVP, Chief Financial Officer) |
S | Common Stock | D | 7255 | $78.29 - $78.29 | $567,993 |
| 2024-02-01 | Edwards Lifesciences Corp | Ullem Scott B.
(CVP, Chief Financial Officer) |
M | Common Stock | A | 7255 | $36.75 - $36.75 | $266,621 |
| 2024-01-12 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
S | Common Stock | D | 10000 | $75.67 - $75.67 | $756,700 |
| 2024-01-12 | Edwards Lifesciences Corp | BOBO DONALD E JR
(CVP,Strategy/Corp Development) |
M | Common Stock | A | 10000 | $36.75 - $36.75 | $367,500 |
| 2023-12-13 | Edwards Lifesciences Corp | Wood Larry L
(Global President TAVR & Surg) |
S | Common Stock | D | 8658 | $71.86 - $71.86 | $622,163 |
| 2023-12-13 | Edwards Lifesciences Corp | Wood Larry L
(Global President TAVR & Surg) |
M | Common Stock | A | 8658 | $45.28 - $45.28 | $392,005 |
| 2023-12-06 | Edwards Lifesciences Corp | Chopra Daveen
(CVP, TMTT) |
S | Common Stock | D | 3500 | $70.00 - $70.00 | $245,005 |
| 2023-12-06 | Edwards Lifesciences Corp | Chopra Daveen
(CVP, TMTT) |
M | Common Stock | A | 3500 | $59.26 - $59.26 | $207,398 |
| 2023-11-13 | Edwards Lifesciences Corp | Wood Larry L
(Global President TAVR & Surg) |
S | Common Stock | D | 8660 | $64.68 - $66.21 | $565,458 |
| 2023-11-13 | Edwards Lifesciences Corp | Wood Larry L
(Global President TAVR & Surg) |
M | Common Stock | A | 8660 | $45.28 - $45.28 | $392,096 |
| 2023-11-03 | Edwards Lifesciences Corp | MUSSALLEM MICHAEL A
(Director) |
S | Common Stock | D | 29350 | $67.18 - $67.18 | $1,971,733 |
| 2023-11-03 | Edwards Lifesciences Corp | MUSSALLEM MICHAEL A
(Director) |
M | Common Stock | A | 29350 | $36.75 - $36.75 | $1,078,612 |
| 2023-11-06 | Edwards Lifesciences Corp | MUSSALLEM MICHAEL A
(Director) |
G | Common Stock | D | 743378 | $0.00 - $0.00 | $0 |
| 2023-10-31 | Edwards Lifesciences Corp | Ullem Scott B.
(CVP, Chief Financial Officer) |
S | Common Stock | D | 7255 | $62.66 - $62.66 | $454,568 |
| 2023-10-31 | Edwards Lifesciences Corp | Ullem Scott B.
(CVP, Chief Financial Officer) |
M | Common Stock | A | 7255 | $36.75 - $36.75 | $266,621 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |